Investment Q&A

Q: Hello 5i, Could you comment on Profound Medical PRN and also the spike in the price today.

Q: The board of directors is proposing to reprice 16,830,00 .36 to 1.00 options at 10 cents. Also the repricing of 9,375,000 options held by insiders appears to be at issue. Should I be concerned???? Your comments please.

Q: Hi 5I, would you switch from EGLX to EAGR for tax loss? If not for tax loss, would you keep EGLX instead ? Thanks.

Q: what is your opinion on the 2023 budget and capital allocation , market does not seem to like it.
dave

Q: Good morning,

Can you tell me your opinion on MAGT. I double my money right now , should I take profit or let it run.

Thank you

Martin

Q: Do you feel Verdes current share price is a relatively safe location to accumulate more shares? The horizon for holding would be 1-2 years with periodic assessments.

Q: An opinion please.

Q: Wondering what has happened with this company. It is now in US funds and no longer halted. Noticed some trading yesterday and today none. Will this be difficult to sell and do you see this trading again. If it does I'm assuming one should sell. Would there be any point in hanging onto it. Also, if no one is buying/selling what is process for getting rid of it to claim a loss? Thank you!

Q: Hi,

Can you provide general comments on D2L's latest earnings release please?
Specifically, any concerns about their 3 month and 9 month adjusted EBITDA (loss) and their updated financial outlook? Other released financial metrics appear to be positive.
Is this still a long term buy?

What is your take on Andlauer's early warning report released Dec 7, ie..."agreements to sell an aggregate of up to 1,760,000 subordinate voting shares in the capital of the Company ("Subordinate Voting Shares"), representing approximately 9.64% of the issued and outstanding Subordinate Voting Shares, for investment purposes."
Almost 10% is quite a lot of shares is it not?
Is this still a long term buy?

I don't currently own any of these shares but they are on my short term watchlist.

Cheers,
Steve

Q: Kraken Robotics has had some significant contract wins lately, including an $8 million contract with a global energy company, a $14 million contract for their undersea batteries, and today a $50 million contract with the Royal Canadian Navy. The stock has roughly doubled in the last 5 months, but is still well off its all time high. The market cap is up to about $115 million. Wondering what you think of this company as a high risk, small investment? Their Q3 showed ytd adjusted EBITDA of $4.4 million, and getting close to reaching profitability with a net loss for the quarter of $0.5 million.

Q: Tudor spun out some assets to Goldstorm, and I now own some Goldstorm shares, in addition to the Tudor shares. It seems the transaction simply took some of my cost base, and applied it as cost to the new shares. Am I reading this right? Basically, nothing has changed, right? Or will I need to record a capital transaction on Tudor?

Q: Hi 5i Team- In a response to a caller on a recent BNN Market Call, the portfolio manager being interviewed stated that Baylin is in the process of a turn-around, has a record backlog of orders, is now profitable, and had heavy insider buying a year ago at $.80 per share. Could you comment on these points and if accurate would you consider this a long term buy, a possible trade opportunity or something to stay away from. Thanks.

Q: Don’t see any other questions about this. Any opinion of note for a gold mining stock?

Q: I'd love to get your thoughts on this company.

Thanks

Q: Hello 5I,
would you consider Guru (the beverage company) and CARG (Car Guru) buys at this time? Seems like GURU could be tempting to make it private... Would you consider this a possibility?
Thank you, Merry Christmas

Q: What do you think of a switch from eglx to Ese? All lot seems to be going right for Ese lately.
When is 5i going to add some names to the growth portfolio?

Q: I see from previous answers you like this company as a buy. BMO just downgraded it with a target of 4 dollars. They cited a 25% reduction in 2023 guidance and a slowdown of M/A. At the same time you have WELL as a hold which keeps raising its guidance and seems to have momentum towards profitability. What is your reasoning.

Q: A full analysis please. In my opinion the metrics are not good however it is being rated a buy by analysts. I am curious as to your thoughts versus theirs. Thanks

Q: I bought some medical start-ups in private placements around 2004 through 2007, including TMD Titan Medical. I bought into the both the Canadian and the US private placements. TMD has had a number of frustrating round-trips. Yesterday December 5, TMD stock saw considerable action both sides of border: opened yesterday at 0.90 Canadian , went up 40% to 1.25 closing the day at C$1.15 on high volume. Collapsed this morning. I see no news to explain the swing. The company sent shareholders anote about a strategic review. Perhaps a takeover is in the wings? Do you have any news on TMD? Would you hold or sell? (Tax loss not useable).

Q: I hold some stock and my average cost is $4.58. could you give me your view on the future of WBR ,
Jim.